Nephrotic syndrome: Difference between revisions

From IDWiki
Content deleted Content added
Imported from text file
 
No edit summary
Line 1: Line 1:
== Definition ==
== Background ==


* Clinical syndrome characterized by massive proteinuria, which results in hypoalbuminema, hyperlipidemia, and edema
* Syndrome characterized by:
* Can be primary (idiopathic) or secondary
** Significant proteinuria > 3g/day
** Hyperlipidemia/lipiduria
** Anasarca
** Hypoalbuminemia <35g/L


=== Etiologies ===
== Differential Diagnosis ==


==== Common ====
* [[Membranous nephropathy]] (24%)
* [[Minimal change disease]] (16%)
* [[Systemic lupus erythematosus]] (14%)
* [[FSGS]] (12%): more common in black patients
* [[Amyloidosis]] (6 to 17%): more common in older patients
* [[Membranoproliferative glomerulonephritis]] (7%)
* [[IgA nephropathy]] (6%)

==== Exhaustive ====
* Non-proliferative glomerulonephritis
* Non-proliferative glomerulonephritis
** Minimal change disease
** [[Minimal change disease]]
*** Primary
*** Primary
*** Drugs
*** Drugs
**** NSAIDs and COX-2 inhibitors
**** [[NSAIDs]] and COX-2 inhibitors
**** Ampicillin, rifampicin, cephalosporins
**** [[Ampicillin]], [[rifampicin]], [[cephalosporins]]
**** Lithium
**** [[Lithium]]
**** D-penicillamine and tiopronin
**** [[D-penicillamine]] and [[tiopronin]]
**** Pamidronate
**** [[Pamidronate]]
**** Sulfasalazine and 5-ASAs
**** Sulfasalazine and [[5-ASA]]
**** Interferon-gamma
**** [[Interferon-gamma]]
*** Neosplasms
*** Neosplasms
**** Hodgkin lymphoma
**** [[Hodgkin lymphoma]]
**** Non-Hodgkin lymphoma
**** [[Non-Hodgkin lymphoma]]
**** Leukemia
**** [[Leukemia]]
*** Lupus nephritis V (membranous nephritis)
*** [[Lupus nephritis]] V (membranous nephritis)
** Focal segmental glomerulosclerosis
** Focal segmental glomerulosclerosis
*** Primary
*** Primary
*** Severe obesity and other hyperfiltration syndromes
*** Severe [[obesity]] and other hyperfiltration syndromes
*** Infections
*** Infections: [[HIV]], [[parvovirus B19]], [[CMV]], [[EBV]]
**** HIV
**** Parvovirus B19
**** CMV
**** EBV
*** Drugs
*** Drugs
**** Heroin
**** Heroin
**** Interferons
**** Interferons
**** Pamidronate
**** [[Pamidronate]]
**** Anabolic steroids
**** Anabolic steroids
**** mTOR inhibitos
**** mTOR inhibitors
**** Calcineurin inhibitos
**** Calcineurin inhibitors
**** Anthracyclines
**** Anthracyclines
**** Lithium
**** Lithium
*** Other
*** Other
**** Sickle cell anemia
**** [[Sickle cell anemia]]
**** Thrombotic microangiopathy
**** [[Thrombotic microangiopathy]]
**** Genetic disorders
**** Genetic disorders
** Membranous nephropathy
** Membranous nephropathy
*** Primary
*** Primary
*** [[Systemic lupus erythematosus]]
*** Lupus
*** Drugs: [[gold]], [[penicillamine]], [[NSAIDs]]
*** Drugs
*** Infections: [[hepatitis B]] and [[hepatitis C]], [[malaria]], [[syphilis]]
**** Gold
**** Penicillamine
**** NSAIDs
*** Infections
**** Hepatitis B and C
**** Malaria
**** Syphilis
*** Neoplasms
*** Neoplasms
**** Non-Hodgkin lymphoma
**** [[Non-Hodgkin lymphoma]]
**** Solid cancers
**** Solid cancers
*** IgG4 disease
*** [[IgG4 disease]]

=== Most common causes ===

* Membranous nephropathy (24 percent)
* Minimal change disease (16 percent)
* Lupus (14 percent)
* FSGS (12 percent): more common in black patients
* Amyloidosis (6 to 17 percent): more common in older patients
* Membranoproliferative glomerulonephritis (7 percent)
* IgA nephropathy (6 percent)

== Epidemiology ==


=== Epidemiology ===
* If < 20 years old
* If < 20 years old
** Minimal change (70%)
** Minimal change (70%)
Line 82: Line 68:
** Minimal change (20%)
** Minimal change (20%)
** Focal segmental glomerulosclerosis (10%)
** Focal segmental glomerulosclerosis (10%)

== Clinical Manifestations ==

* Edema progressing to anasarca
* Found to have proteinuria, hyperlipidemia, and hypoalbuminemia on investigations

== Investigations ==

* Urine protein
* Lipid panel
* Albumin levels

== Diagnosis ==
* Significant proteinuria > 3g/day
* Hyperlipidemia/lipiduria
* Anasarca
* Hypoalbuminemia <35g/L


== Management ==
== Management ==

Revision as of 16:02, 2 March 2026

Background

  • Clinical syndrome characterized by massive proteinuria, which results in hypoalbuminema, hyperlipidemia, and edema
  • Can be primary (idiopathic) or secondary

Etiologies

Common

Exhaustive

Epidemiology

  • If < 20 years old
    • Minimal change (70%)
    • Membranous (20%)
    • Focal segmental glomerulosclerosis (10%)
  • If > 20 years old
    • Membranous (70%)
    • Minimal change (20%)
    • Focal segmental glomerulosclerosis (10%)

Clinical Manifestations

  • Edema progressing to anasarca
  • Found to have proteinuria, hyperlipidemia, and hypoalbuminemia on investigations

Investigations

  • Urine protein
  • Lipid panel
  • Albumin levels

Diagnosis

  • Significant proteinuria > 3g/day
  • Hyperlipidemia/lipiduria
  • Anasarca
  • Hypoalbuminemia <35g/L

Management

  • If < 20 years old
    • Treat empirically with steroids, as the majority are primary minimal change disease
  • If > 20 years old
    • Needs kidney biopsy to direct treatment